TRIM27 promotes IL-6-induced proliferation and inflammation factor production by activating STAT3 signaling in HaCaT cells

被引:57
|
作者
Miao, Xiao [1 ,2 ]
Xiang, Yanwei [1 ,3 ]
Mao, Weiwei [1 ]
Chen, Yiran [1 ]
Li, Qi [1 ]
Fan, Bin [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Yueyang Hosp Integrated Tradit Chinese & Western, Dept Dermatol, 110 Gan He Rd, Shanghai 200437, Peoples R China
[2] Shanghai Univ Tradit Chinese Med, Innovat Res Inst Tradit Chinese Med, Shanghai, Peoples R China
[3] Shanghai Univ Tradit Chinese Med, Sch Rehabil Sci, Shanghai, Peoples R China
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2020年 / 318卷 / 02期
基金
中国国家自然科学基金;
关键词
PIAS3; psoriasis; STAT3; TRIM27; ubiquitination; IFN-GAMMA; PSORIASIS; IL-6; EXPRESSION; CARCINOMA;
D O I
10.1152/ajpcell.00314.2019
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The IL-6/STAT3 signaling pathway is required for the development of psoriatic lesions, and tripartite motif-containing 27 (TRIM27) is a protein inhibitor of activated STAT3 (PIAS3)-interacting protein that could modulate IL-6-induced STAT3 activation. However, whether TRIM27 is associated with the IL-6/STAT3 signaling pathway in psoriasis remains enigmatic. TRIM27 expression and gene set enrichment analysis in patients with psoriasis were determined using bioinformatics. Human keratinocyte HaCaT cells treated with recombinant protein IL-6 (rh-IL-6) were transduced with lentivirus silencing TRIM27 and/or PIAS3 or, otherwise, transduced with lentivirus expressing TRIM27 and/or lentivirus silencing STAT3, or MG132, a proteasome-specific protease inhibitor. Cell proliferation and inflammation factor production were measured using Cell Counting Kit-8 and ELISA, respectively. TRIM27, proliferation marker protein Ki-67 (Ki67), phospho-STAT3 (pSTAT3), STAT3, and PIAS3 expressions were determined using real-time quantitative PCR, immunofluorescence staining, or Western blot analysis. Coimmunoprecipitation combined with ubiquitination analysis was performed to explore the interaction between TRIM27 and PIAS3. In the present study, TRIM27 expression was increased in psoriatic lesions, associated with the IL-6 signaling pathway, and induced by rh-IL-6 in a time-dependent manner. The increased cell proliferation, inflammation factor production, and expression of Ki67 and of p-STAT3 relative to STAT3 induced by rh-IL-6 and TRIM27 overexpression were significantly inhibited by TRIM27 silencing and STAT3 silencing, respectively. More importantly, TRIM27 interacted with PIAS3, and its overexpression promoted PIAS3 ubiquitination in HaCaT cells. PIAS3 silencing also significantly promoted TRIM27dependent and 1L6-induced STAT3 activation, cell proliferation, and inflammation factor production. In conclusion, our results highlight that TRIM27 expression is significantly increased by IL-6 and suggest a TRIM27/STAT3-dependent mechanism for regulation of inflammation and proliferation-associated development of psoriasis.
引用
收藏
页码:C272 / C281
页数:10
相关论文
共 50 条
  • [1] METTL14 promotes IL-6-induced viability, glycolysis and inflammation in HaCaT cells via the m6A modification of TRIM27
    Chen, Yiran
    Xiang, Yanwei
    Miao, Xiao
    Kuai, Le
    Ding, Xiaojie
    Ma, Tian
    Li, Bin
    Fan, Bin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2024, 28 (03)
  • [2] Qinzhu Liangxue inhibits IL-6-induced hyperproliferation and inflammation in HaCaT cells by regulating METTL14/SOCS3/STAT3 axis
    Chen, Yiran
    Miao, Xiao
    Xiang, Yanwei
    Kuai, Le
    Ding, Xiaojie
    Ma, Tian
    Li, Bin
    Fan, Bin
    JOURNAL OF ETHNOPHARMACOLOGY, 2023, 317
  • [3] ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling
    Hu, Yabing
    Huang, Yongchu
    Xie, Xiaohang
    Li, Longshan
    Zhang, Yong
    Zhang, Xiaochao
    CANCER CELL INTERNATIONAL, 2023, 23 (01)
  • [4] c-Met signaling promotes IL-6-induced myeloma cell proliferation
    Hov, Hakon
    Tian, Erming
    Holien, Toril
    Holt, Randi Utne
    Vatsveen, Thea K.
    Fagerli, Unn-Merete
    Waage, Anders
    Borset, Magne
    Sundan, Anders
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2009, 82 (04) : 277 - 287
  • [5] TRIM52 promotes colorectal cancer cell proliferation through the STAT3 signaling
    Pan, Shengli
    Deng, Yingying
    Fu, Jun
    Zhang, Yuhao
    Zhang, Zhijin
    Ru, Xiaokun
    Qin, Xianju
    CANCER CELL INTERNATIONAL, 2019, 19 (1)
  • [6] Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation
    Kiesel, Brian F.
    Parise, Robert A.
    Guo, Jianxia
    Huryn, Donna M.
    Johnston, Paul A.
    Colombo, Raffaele
    Sen, Malabika
    Grandis, Jennifer R.
    Beumer, Jan H.
    Eiseman, Julie L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 78 (06) : 1225 - 1235
  • [7] Plakevulin A induces apoptosis and suppresses IL-6-induced STAT3 activation in HL60 cells
    Kabasawa, Misaki
    Furuta, Masateru
    Ibayashi, Yuuka
    Kanemaru, Kaori
    Kohatsu, Haruki
    Kuramochi, Fumiyo
    Yamatoya, Kenji
    Nakata, Kazuya
    Nakamura, Yoshikazu
    Tomoshige, Shusuke
    Ohgane, Kenji
    Furuyama, Yuuki
    Takasawa, Ryoko
    Kobayashi, Susumu
    Sugawara, Fumio
    Ikekita, Masahiko
    Kuramochi, Kouji
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2024, 110
  • [8] OGT regulated O-GlcNacylation promotes migration and invasion by activating IL-6/STAT3 signaling in NSCLC cells
    Ge, Xin
    Peng, Xiao
    Li, Mengmeng
    Ji, Feng
    Chen, Jinliang
    Zhang, Dongmei
    PATHOLOGY RESEARCH AND PRACTICE, 2021, 225
  • [9] A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells
    Lin, Li
    Benson, Don M., Jr.
    DeAngelis, Stephanie
    Bakan, Courtney E.
    Li, Pui-Kai
    Li, Chenglong
    Lin, Jiayuh
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (06) : 1459 - 1469
  • [10] LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation
    Liao, Q.
    Zeng, Z.
    Guo, X.
    Li, X.
    Wei, F.
    Zhang, W.
    Li, X.
    Chen, P.
    Liang, F.
    Xiang, B.
    Ma, J.
    Wu, M.
    Tang, H.
    Deng, M.
    Zeng, X.
    Tang, K.
    Xiong, W.
    Li, G.
    ONCOGENE, 2014, 33 (16) : 2098 - 2109